A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861

Abstract Background Treatment with tumor-targeted toxins attempts to overcome the disadvantages of conventional cancer therapies by directing a drug’s cytotoxic effect specifically towards cancer cells. However, success with targeted toxins has been hampered as the constructs commonly remain bound t...

Full description

Bibliographic Details
Main Authors: Finn J. Schulze, Mazdak Asadian-Birjand, Michael Pradela, Nicole Niesler, Gregor Nagel, Hendrik Fuchs
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Biotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12896-024-00854-5